Growth hormone study for short children born small for gestational age
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child was born full-term (37 to 41 weeks) with a birth weight below the 10th percentile for their gestational age and sex.
- Your child is at least 3 years old and has not started puberty yet (no signs like breast development or testicle growth).
- Your child's height is significantly below average (more than 2 standard deviations shorter than other kids their age and sex).
- Bone age (from an X-ray of the hand) is not more than 1 year older than their actual age.
- Your child has never taken growth hormone, IGF-1, or any ghrelin-like medicine before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new growth hormone injection (Jinpei) to help children who were born small for gestational age (SGA) and are still short for their age. The treatment may help them grow taller.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.
This study tests a new once-a-week injection (GenSci134) for children with growth hormone deficiency. It aims to see if it is safe and helps them grow. Your child may be able to join if they have not been treated before and meet the age and height requirements.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
This study tests an experimental growth hormone (Inpegsomatropin) to help children born small for gestational age who remain short. If your child meets the specific height, age, and puberty criteria, they may qualify.
Hear when a new Short Stature Children Born Small for Gestational Age (SGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.